.
@C_MatheyAndrews
just presented at the plenary session of
#AATS2023
!! Prevalence of MSK injuries among CT surgeons is 64%; 14% of surgeons take a leave of absence or retire early. It is critical to implement ergonomics-directed education in the OR. Great commentary by
@MMaddaus
SO proud of our MGH thoracic team at
#STS2023
!!! Andrea Axtell,
@C_MatheyAndrews
&
@alexandra_p_24
gave phenomenal full-length podium presentations on important topics in lung cancer & thoracic surgery. Congratulations to Andrea for winning the best paper award!!!
@mghctsurgery
Congratulations to Dusty Donaldson for winning the 2022
@IASLC
Patient Advocacy Award. We really appreciate her tremendous efforts and leadership!! This is her foundation’s website:
#WCLC2022
#WCLC22
#lungcancer
@dustywater
She made it!! MGH surgery resident
@C_MatheyAndrews
just flew into Singapore from Boston at 9:30 am. Now at speaker ready room uploading slides for a 10:45 am oral presentation on sublobar resection vs lobectomy for NSCLC w/ high risk features
#WCLC23
(Rm: Nicoll 3).
@MGHSurgery
.
@AltorkiNasser
just presented practice-changing, landmark CALGB140503. No difference in disease-free and overall survival between sublobar vs lobectomy for peripheral T1N0 NSCLC tumors <2 cm. 59% in SLR arm were wedges.
#lungcancer
#WCLC2022
@IASLC
At
#STS2023
,
@alexandra_p_24
presented findings from the National Lung Screening Trial showing that the 10-year survival rate among stage IA lung cancer patients undergoing lobectomy was only 55%. Clearly much more needs to be done to help our earliest stage lung cancer patients.
On this
#WorldLungCancerDay
, our team
@AmLungCSI
wants to thank the organizations and leaders who have worked with us to raise awareness about
#screening
. This summer, ALCSI has had 60+ events across the US, reaching over 5000 individuals with screening information and resources!
1st day of the White Ribbon relay!!! 1 ribbon from the east coast & 1 on the west coast will travel cross country & land in Colorado, home of Heidi & the 1st
#whiteribbon
to raise
#lungcancer
awareness!! Our ALCSI Wellesley team handed off the ribbon to our Boston team today!!
These are the best papers in thoracic surgery / thoracic oncology in the past year, as curated by
@LindaMThoracic
&
@ShandaBlackmon
. I’m attaching pictures of all the papers in this thread. If there are any you think should be included, please reply to this tweet. At
#GTSC23
Today,
@alexandra_p_24
gave an important presentation at
#AATS2023
on the limitations of
#lungcancerscreening
guidelines & potential solutions. Less than 60% of patients w/ lung cancer in the SCCS would have qualified for screening under the newest USPSTF guidelines.
@AmLungCSI
Thank you so much
@GovernorTomWolf
for working with ALCSI to spread awareness about
#lungcancer
and screening during
#LCAM
🌟 We are incredibly grateful for Gov Wolf’s tremendous support! Check out Gov Wolf’s announcement and his ALCSI shout-out at
.
@chris_dickhoff
presents results from INCREASE trial (surgery after chemoRT+I/O for borderline resectable NSCLC): 63% pCR, 79% major pathologic response, only 15% radiographic response (may be related to nodal flare?). Insightful discussion from
@PatelOncology
.
#WCLC23
Carrie Cunningham just gave the greatest Presidential Address. She taught us invaluable lessons on mental health, depression, substance abuse, and “taking care of yourself.” She is an incredible human being, visionary surgeon & leader.
@AcademicSurgery
@lubitz_carrie
#ASC2023
Paradigm-shifting study by
@ekslim
et al: MARS-2 trial w/
@paugalde20
discussion. pleurectomy / decortication + chemo Vs chemo. Surgery had worse OS: HR 1.28, p=0.03. 2nd landmark surgery RCT from the UK team presented at
#WCLC23
by
@ekslim
in past 3 years.
At
#WCLC23
,
@alexandra_p_24
presents analysis of SCCS & Black women’s health study. One simple revision to the USPSTF LCS guidelines (replacing the 20-pack yr cutoff with a 20-yr duration cutoff) increases sensitivity & eliminates racial disparities in screening eligibility.
The 2022 Lung Cancer Heroes: Alesha Arnold, Pierre de Delva & Estela Rodriguez!! CONGRATULATIONS!! Pierre was my fellow when I was a student
@MGHSurgery
— an absolutely phenomenal surgeon & person!! Powerful & inspirational keynote by
@chrisdraft
!!
#NACLC22
@IASLC
@ummcsurgery
Study just published
@jamaonc
: among people with light smoking histories and people who stopped smoking >15 years ago (these are people not currently eligible for screening) the risk of lung cancer is 10 times higher than people who do not smoke
@aamdmph
Congratulations to
@PriyankaSenth16
for winning the IASLC Early Career Award!! She will be presenting on the burden of COVID-19 on lung cancer patients during periods of high transmission of SARS-CoV-2 tomorrow (Monday room 405B, 12-1pm)
#WCLC23
Profound distinguished lecture by
@jdoningtonmd
. She introduced “RIOT”: return to intended oncologic treatment. In 4 recent periop chemo/IO RCTs, only about half of pts completed all phases of care. Surgeons need to “make RIOT a priority” & “an important quality metric.”
#WCLC23
.
Check out
@JVelottaMD
interview: Dr. Velotta is a phenomenal surgeon,
@amlungcsi
advisor & huge
@TheWRP4LC
supporter!! Help him spread awareness of UCSF/UCDavis/Stanford study on Asian women who have never smoked w/ lung cancer:
Dr. Lecia Sequist
@LeciaSequist
gave a spectacular talk on Sybil to open Session
#4
of the CT Screening Symposium at
#WCLC2023
!! Dr. Sequist and her team developed Sybil, a deep learning algorithm that can predict lung cancer risk over 6 years from a LDCT scan.
Congratulations to the amazing Alex Potter (
@alexandra_p_24
) for winning 🥇 at Harvard Surgery Research Day for her study on suicide in cancer surgery patients:
She’s the youngest winner in the history of the competition!!!
.
@PriyankaSenth16
& the Rice ALCSI team presented white ribbons and
#lungcancer
screening info at the International Diwali Dussehra Festival in Houston!! The team also walked in the parade to bring attention to screening to the 10,000 people at the event.
@AmLungCSI
@TheWRP4LC
The long-awaited results of RCT JCOG0802 reported earlier today at AATS. Segmentectomy associated with improved survival when compared to lobectomy for tumors≤2cm, CTR>0.5, clinical stage IA NSCLC. Landmark achievement by Dr. Asamura and colleagues!
#AATS2021
#JCOG0802
It's impossible to overstate their contribution to
#lungcancer
screening
#lcsm
#lcam
Andrea McKee, M.D. and the late Brady McKee, M.D. to be honored with the James L. Mulshine, M.D., National Leadership Award via
@preventcancer
Congratulations to ALCSI’s Chinmay Haridas on winning the
@IASLC
Developing Nations
#Education
Award & on giving an outstanding presentation on sublobar resection vs lobectomy for stage IA (<2cm) small cell
#lungcancer
!!
#WCLC23
Dr. Mike Gieske gave a phenomenal talk at
@NLCRTnews
on engaging primary care to accelerate
#lungcancer
screening. He highlighted the impressive work (and trajectory) of St. Elizabeth’s screening program.
@mrgieske
@StElizabethNKY
The Rice ALCSI team held a
#lungcancer
screening awareness event with the Rice Student Volunteer Program for 100+ elementary & middle school students & their parents. Thank you to all who signed our ribbons from
@TheWRP4LC
!! Building momentum into lung cancer awareness month!!
Great talk on standard 5.8 lymph node dissection and the 1+3 rule by
@LindaMThoracic
. Check out the new videos on mediastinal lymph node identification by Khalid Ahmer & Nirmal Veeramachaneni!! At
#GTSC23
.
@DoctorJSpicer
gave a great talk on complications associated with neoadjuvant chemoRT and why the field has moved to induction chemo + immunotherapy. He also noted work by
@AltorkiNasser
on SBRT+immunotherapy (without chemo) as a potential future neoadjuvant regimen
#GTSC23
This slide is a brief summary by
@LindaMThoracic
on clinical trials relevant to thoracic surgeons. For those interested in participating in or leading clinical trials, every year, Dr. Linda Martin puts together an incredible program on Ginsberg clinical trials day at
#GTSC23
Great talk on
#lungcancer
risk assessment using biomarkers by
@hilaryarobbins
. biomarkers can refine screening eligibility but “study design is paramount to define intended use of the biomarkers and quantify its added value.”
@IARCWHO
#WCLC22
@IASLC
.
@AmLungCSI
’s
@alexandra_p_24
presents data from the National Lung Screening Trial @
#WCLC2022
: 6% of pts w/ stage I-III
#lungcancer
developed a 2nd primary lung cancer. >27% of metachronous 2nd primary lung cancers diagnosed >4 years after diagnosis date of 1st primary.
#lcsm
Landmark trial by
@AltorkiNasser
and colleagues published in
@NEJM
. 17 years in the making. Together with JCOG0802, findings are practice changing in our field of thoracic surgery.
.
@dustywater
gave a phenomenal presentation at the World Conference on Lung Cancer in Singapore on her innovative program that gives media training for patients to help them w/their efforts to raise
#lungcancer
awareness. We really appreciate your leadership Dusty!!
@LungCAN
A beautiful day at
@UNC
to raise
#lungcancer
awareness with
@heidi_onda
, the absolutely inspirational founder of the
#WhiteRibbonProject
!! Our Carolina ALCSI team was also really excited to finally meet UNC thoracic surgeon, Dr. Gita Mody in person!!
@gitamody
Our group, led by
@arianmansur
, found that for patients with pT1-2 N0 M0 combined small cell lung cancer, surgery alone is associated with similar outcomes to surgery + adjuvant chemotherapy:
@alexx_nees
@annalsthorsurg
Today is the 1st day of
#lungcancerawarenessmonth
!! Here’s a video by Natalie Wing & Meghan McCarthy on the first-ever white ribbon relay to raise awareness of lung cancer &
#lungcancerscreening
!! Visit to learn more!!
#LCAM
Today, our
#westcoast
white ribbon embarked on its journey in the
#whiteribbonrelay
from
#USC
to
#UCLA
. It will make its way up through our CA chapters to WA, and come back down to TX and several central states before arriving in Colorado filled with signatures!
@amlungcsi